Thomas Boyer

Dr. Thomas Boyer is a Professor in the Department of Molecular Medicine at UT Health San Antonio, specializing in the molecular mechanisms of uterine fibroids and related oncogenic pathways. His research focuses on MED12 mutations, Wnt/β-catenin signaling, and epigenetic reprogramming in uterine tumors.

• NIH R01 Grant ($1.56 million)
• NIH R01 Multi-PI Grant ($3.8 million)

Dr. Boyer's work explores the interplay between vitamin D deficiency and genomic instability in MED12-mutant uterine fibroids, aiming to develop non-surgical therapies. He collaborates with Dr. Robert Schenken (UT Health San Antonio) and Dr. Ayman Al-Hendy (University of Illinois at Chicago).

His recent publications highlight:

• Mediator kinase module as a therapeutic target in oncogenic Wnt signaling
• Role of BET proteins in inflammation and fibroid progression
• Epigenetic reprogramming via N6-methyladenosine in fibroid pathogenesis
• Myeloid-derived suppressor cells in cancer immunosuppression